Does Icodextrin Reduce the Risk of Small Bowel Obstruction?
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The study aims at investigating if icodextrin 4% instilled in abdominal cavity during surgery
can reduce the risk of surgery and hospitalisation for small bowel obstruction in patients
with colorectal cancer. Follow-up data is collected from the Swedish national colorectal
cancer registry.Patients are followed for 5 years postoperatively.The study is a randomized
Swedish multicenter study and planned to include 1,800 patients. A safety control is planned
after 300 included patients.